title: [Atrial fibrillation: therapeutic options at the turn of the century.].
abstract: Atrial fibrillation is an increasing health care problem and the incidence of this arrhythmia is expected to increase substantially in the next two decades. Atrial fibrillation can be seen in patients with structural heart disease as well as those who have a normal heart. A variety of underlying mechanisms can lead to atrial fibrillation, including parasympathetic stimulation causing vagal atrial fibrillation. Complications of atrial fibrillation include congestive heart failure and stroke. Atrial fibrillation is an independent risk factor for increased mortality. In recent years a number of new treatment options have emerged. Anticoagulation decreases the risk of stroke and new antiarrhythmic drugs have been developed which increase the likelihood of conversion to and subsequent maintenance of sinus rhythm. In addition there have been advances in the approach to electrical cardioversion. Radiofrequency ablation therapy is a promising option in the treatment of atrial fibrillation and could be increasingly utilized in the near future. This paper focuses on advances in the therapy of atrial fibrillation, including new pharmacological agents, radiofrequency ablation and electrical cardioversion.
authors.affiliation: Division of internal medicine, Landspitali University Hospital, Hringbraut, 101 Reykjavík, Iceland. davidar@landspitali.is.
authors.forename: I J
authors.initials: IJ
authors.lastname: Guðmundsdóttir
authors.forename: D O
authors.initials: DO
authors.lastname: Arnar